2023-04-012024-03-312024-03-31false12210146BURGWAY LTD2024-09-06iso4217:GBPxbrli:pure122101462023-04-01122101462024-03-31122101462023-04-012024-03-31122101462022-04-01122101462023-03-31122101462022-04-012023-03-3112210146bus:SmallEntities2023-04-012024-03-3112210146bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3112210146bus:FullAccounts2023-04-012024-03-3112210146bus:PrivateLimitedCompanyLtd2023-04-012024-03-3112210146core:WithinOneYear2024-03-3112210146core:AfterOneYear2024-03-3112210146core:WithinOneYear2023-03-3112210146core:AfterOneYear2023-03-3112210146core:ShareCapital2024-03-3112210146core:SharePremium2024-03-3112210146core:RevaluationReserve2024-03-3112210146core:OtherReservesSubtotal2024-03-3112210146core:RetainedEarningsAccumulatedLosses2024-03-3112210146core:ShareCapital2023-03-3112210146core:SharePremium2023-03-3112210146core:RevaluationReserve2023-03-3112210146core:OtherReservesSubtotal2023-03-3112210146core:RetainedEarningsAccumulatedLosses2023-03-3112210146core:LandBuildings2024-03-3112210146core:PlantMachinery2024-03-3112210146core:Vehicles2024-03-3112210146core:FurnitureFittings2024-03-3112210146core:OfficeEquipment2024-03-3112210146core:NetGoodwill2024-03-3112210146core:IntangibleAssetsOtherThanGoodwill2024-03-3112210146core:ListedExchangeTraded2024-03-3112210146core:UnlistedNon-exchangeTraded2024-03-3112210146core:LandBuildings2023-03-3112210146core:PlantMachinery2023-03-3112210146core:Vehicles2023-03-3112210146core:FurnitureFittings2023-03-3112210146core:OfficeEquipment2023-03-3112210146core:NetGoodwill2023-03-3112210146core:IntangibleAssetsOtherThanGoodwill2023-03-3112210146core:ListedExchangeTraded2023-03-3112210146core:UnlistedNon-exchangeTraded2023-03-3112210146core:LandBuildings2023-04-012024-03-3112210146core:PlantMachinery2023-04-012024-03-3112210146core:Vehicles2023-04-012024-03-3112210146core:FurnitureFittings2023-04-012024-03-3112210146core:OfficeEquipment2023-04-012024-03-3112210146core:NetGoodwill2023-04-012024-03-3112210146core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112210146core:ListedExchangeTraded2023-04-012024-03-3112210146core:UnlistedNon-exchangeTraded2023-04-012024-03-3112210146core:MoreThanFiveYears2023-04-012024-03-3112210146core:Non-currentFinancialInstruments2024-03-3112210146core:Non-currentFinancialInstruments2023-03-3112210146dpl:CostSales2023-04-012024-03-3112210146dpl:DistributionCosts2023-04-012024-03-3112210146core:LandBuildings2023-04-012024-03-3112210146core:PlantMachinery2023-04-012024-03-3112210146core:Vehicles2023-04-012024-03-3112210146core:FurnitureFittings2023-04-012024-03-3112210146core:OfficeEquipment2023-04-012024-03-3112210146dpl:AdministrativeExpenses2023-04-012024-03-3112210146core:NetGoodwill2023-04-012024-03-3112210146core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112210146dpl:GroupUndertakings2023-04-012024-03-3112210146dpl:ParticipatingInterests2023-04-012024-03-3112210146dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112210146core:ListedExchangeTraded2023-04-012024-03-3112210146dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112210146core:UnlistedNon-exchangeTraded2023-04-012024-03-3112210146dpl:CostSales2022-04-012023-03-3112210146dpl:DistributionCosts2022-04-012023-03-3112210146core:LandBuildings2022-04-012023-03-3112210146core:PlantMachinery2022-04-012023-03-3112210146core:Vehicles2022-04-012023-03-3112210146core:FurnitureFittings2022-04-012023-03-3112210146core:OfficeEquipment2022-04-012023-03-3112210146dpl:AdministrativeExpenses2022-04-012023-03-3112210146core:NetGoodwill2022-04-012023-03-3112210146core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3112210146dpl:GroupUndertakings2022-04-012023-03-3112210146dpl:ParticipatingInterests2022-04-012023-03-3112210146dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3112210146core:ListedExchangeTraded2022-04-012023-03-3112210146dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3112210146core:UnlistedNon-exchangeTraded2022-04-012023-03-3112210146core:NetGoodwill2024-03-3112210146core:IntangibleAssetsOtherThanGoodwill2024-03-3112210146core:LandBuildings2024-03-3112210146core:PlantMachinery2024-03-3112210146core:Vehicles2024-03-3112210146core:FurnitureFittings2024-03-3112210146core:OfficeEquipment2024-03-3112210146core:AfterOneYear2024-03-3112210146core:WithinOneYear2024-03-3112210146core:ListedExchangeTraded2024-03-3112210146core:UnlistedNon-exchangeTraded2024-03-3112210146core:ShareCapital2024-03-3112210146core:SharePremium2024-03-3112210146core:RevaluationReserve2024-03-3112210146core:OtherReservesSubtotal2024-03-3112210146core:RetainedEarningsAccumulatedLosses2024-03-3112210146core:NetGoodwill2023-03-3112210146core:IntangibleAssetsOtherThanGoodwill2023-03-3112210146core:LandBuildings2023-03-3112210146core:PlantMachinery2023-03-3112210146core:Vehicles2023-03-3112210146core:FurnitureFittings2023-03-3112210146core:OfficeEquipment2023-03-3112210146core:AfterOneYear2023-03-3112210146core:WithinOneYear2023-03-3112210146core:ListedExchangeTraded2023-03-3112210146core:UnlistedNon-exchangeTraded2023-03-3112210146core:ShareCapital2023-03-3112210146core:SharePremium2023-03-3112210146core:RevaluationReserve2023-03-3112210146core:OtherReservesSubtotal2023-03-3112210146core:RetainedEarningsAccumulatedLosses2023-03-3112210146core:NetGoodwill2022-04-0112210146core:IntangibleAssetsOtherThanGoodwill2022-04-0112210146core:LandBuildings2022-04-0112210146core:PlantMachinery2022-04-0112210146core:Vehicles2022-04-0112210146core:FurnitureFittings2022-04-0112210146core:OfficeEquipment2022-04-0112210146core:AfterOneYear2022-04-0112210146core:WithinOneYear2022-04-0112210146core:ListedExchangeTraded2022-04-0112210146core:UnlistedNon-exchangeTraded2022-04-0112210146core:ShareCapital2022-04-0112210146core:SharePremium2022-04-0112210146core:RevaluationReserve2022-04-0112210146core:OtherReservesSubtotal2022-04-0112210146core:RetainedEarningsAccumulatedLosses2022-04-0112210146core:AfterOneYear2023-04-012024-03-3112210146core:WithinOneYear2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112210146core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112210146core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112210146core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3112210146core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3112210146core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3112210146bus:Director12023-04-012024-03-3112210146bus:Director22023-04-012024-03-31

BURGWAY LTD

Registered Number
12210146
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

BURGWAY LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

Dr Alan Burgin
Mrs Jessie Burgin

Registered Address

Pfm Dental, Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

12210146 (England and Wales)
BURGWAY LTD
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets36,1112,194
6,1112,194
Current assets
Debtors419,52880,798
Cash at bank and on hand118,83019,790
138,358100,588
Creditors amounts falling due within one year5(39,852)(38,140)
Net current assets (liabilities)98,50662,448
Total assets less current liabilities104,61764,642
Provisions for liabilities6(1,161)(417)
Net assets103,45664,225
Capital and reserves
Called up share capital22
Profit and loss account103,45464,223
Shareholders' funds103,45664,225
The financial statements were approved and authorised for issue by the Board of Directors on 6 September 2024, and are signed on its behalf by:
Dr Alan Burgin
Director
Registered Company No. 12210146
BURGWAY LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Office Equipment25
Related parties
During the year the Director loaned the company £21,818 (2023: - 61,573). This loan is repayable upon demand. Interest was charged on the loan balance at the UK market rate on a monthly basis.
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 233,9643,964
Additions5,9545,954
At 31 March 249,9189,918
Depreciation and impairment
At 01 April 231,7701,770
Charge for year2,0372,037
At 31 March 243,8073,807
Net book value
At 31 March 246,1116,111
At 31 March 232,1942,194
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables19,41019,129
Other debtors-61,573
Prepayments and accrued income11896
Total19,52880,798
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security39,36838,140
Other creditors484-
Total39,85238,140
6.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)1,161417
Total1,161417